APPLICATION
NDA020745
TYPE
NDA
ORIGINAL APPROVAL
1998-02-26
LATEST ACTION
1999-03-08
ROUTE
ORAL
DOSAGE FORM
TABLET, EFFERVESCENT
MARKETING STATUS
Discontinued
Products
ZANTAC 75 · ReferenceDiscontinued
RANITIDINE HYDROCHLORIDE EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, EFFERVESCENT · ORAL
Approval history
1999-03-08Efficacy · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.